JW (Cayman) Therapeutics Co. Ltd
HKEX:2126.HK
1.4 (HKD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 869.034 | 1,005.909 | 1,373.222 | 1,553.126 | 1,781.404 | 2,243.957 | 2,651.744 | 3,122.81 | 946.318 | 288.994 | 0 |
| Short Term Investments
| 0 | 5.534 | 0 | 5.544 | 35.427 | 0.695 | 0 | 0.863 | 1.975 | 0.087 | 0 |
| Cash and Short Term Investments
| 869.034 | 1,005.909 | 1,373.222 | 1,553.126 | 1,816.831 | 2,243.957 | 2,651.744 | 3,122.81 | 946.318 | 288.994 | 0 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 50.607 | 34.778 | 44.294 | 63.347 | 30.959 | 47.685 | 18.283 | 3.418 | 0 | 0 | 0 |
| Other Current Assets
| 24.725 | 4.006 | 27.253 | 50.824 | 54.237 | 28.544 | 46.592 | 14.943 | 8.718 | 6.474 | 0 |
| Total Current Assets
| 944.366 | 1,067.484 | 1,446.917 | 1,667.457 | 1,918.455 | 2,318.137 | 2,726.025 | 3,138.815 | 954.155 | 292.334 | 0 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 304.586 | 343.11 | 400.893 | 442.037 | 465.36 | 466.028 | 405.659 | 366.487 | 295.267 | 248.014 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 717.138 | 718.298 | 996.701 | 1,011.194 | 1,003.991 | 1,006.338 | 996.246 | 926.577 | 923.621 | 175.56 | 0 |
| Goodwill and Intangible Assets
| 717.138 | 718.298 | 996.701 | 1,011.194 | 1,003.991 | 1,006.338 | 996.246 | 926.577 | 923.621 | 175.56 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 13.731 | 17.205 | 16.923 | 13.267 | 5.687 | 21.934 | 60.224 | 49.238 | 45.16 | 32.006 | 0 |
| Total Non-Current Assets
| 1,035.455 | 1,078.613 | 1,414.517 | 1,466.499 | 1,475.039 | 1,494.3 | 1,462.128 | 1,342.302 | 1,264.047 | 455.58 | 0 |
| Total Assets
| 1,979.821 | 2,146.097 | 2,861.434 | 3,133.956 | 3,393.493 | 3,812.437 | 4,188.153 | 4,481.118 | 2,218.202 | 747.914 | 0 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 51.353 | 3.269 | 6.825 | 7.604 | 5.396 | 2.565 | 11.586 | 0.902 | 0 | 0 | 0 |
| Short Term Debt
| 206.083 | 121.005 | 227.234 | 152.9 | 22.342 | 20.186 | 16.602 | 10.881 | 10.135 | 10.096 | 0 |
| Tax Payables
| 0 | 6.622 | 2.411 | 4.028 | 3.312 | 5.468 | 3.372 | 1.881 | 0.512 | 0.331 | 0 |
| Deferred Revenue
| 0 | 105.816 | 28.215 | 1.123 | 0.517 | 1.763 | 1.349 | 8.052 | 4.995 | 1.181 | 0 |
| Other Current Liabilities
| 65.99 | 133.573 | 139.555 | 146.303 | 162.766 | 170.681 | 165.821 | 267.386 | 189.439 | 112.39 | 0 |
| Total Current Liabilities
| 323.426 | 264.469 | 376.025 | 348.987 | 193.816 | 243.308 | 237.227 | 281.05 | 219.216 | 137.383 | 0 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 174.451 | 197.79 | 163.403 | 126.228 | 127.68 | 126.849 | 109.463 | 112.712 | 2,749.564 | 1,488.141 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 21.984 | 28.321 | 22.098 | 20.924 | 262.884 | 176.487 | 0 |
| Total Non-Current Liabilities
| 174.451 | 197.79 | 176.282 | 141.721 | 149.664 | 155.17 | 131.561 | 133.636 | 3,012.448 | 1,664.628 | 0 |
| Total Liabilities
| 497.877 | 462.259 | 552.307 | 490.708 | 343.48 | 398.478 | 368.788 | 414.686 | 3,231.664 | 1,802.01 | 0 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.027 | 0.027 | 0.029 | 0.03 | 0.032 | 0.033 | 0.032 | 0.031 | 0.008 | 0.004 | 0 |
| Retained Earnings
| -5,205.601 | -4,965.334 | -4,938.57 | -4,712.518 | -4,431.39 | -4,099.411 | -3,520.975 | -3,140.613 | -1,791.432 | -1,101.897 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 606.463 | 6,649.145 | 687.595 | 528.625 | 353.602 | 75.068 | 99.703 | 65.846 | 45.191 | 2.365 | 0 |
| Other Total Stockholders Equity
| 6,081.055 | 6,080.787 | 6,249.494 | 6,369.724 | 7,179.711 | 6,703.768 | 7,257.35 | 7,151.478 | 866.404 | 42.729 | 0 |
| Total Shareholders Equity
| 1,481.944 | 1,683.838 | 2,309.127 | 2,643.248 | 3,050.013 | 3,413.959 | 3,819.365 | 4,066.432 | -1,013.462 | -1,054.096 | 0 |
| Total Equity
| 1,481.944 | 1,683.838 | 2,309.127 | 2,643.248 | 3,050.013 | 3,413.959 | 3,819.365 | 4,066.432 | -1,013.462 | -1,054.096 | 0 |
| Total Liabilities & Shareholders Equity
| 1,979.821 | 2,146.097 | 2,861.434 | 3,133.956 | 3,393.493 | 3,812.437 | 4,188.153 | 4,481.118 | 2,218.202 | 747.914 | 0 |